Syngene International to invest $100mn annually in research and biologics
The company has made a cumulative investment of approximately Rs 4,500 crores.
Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company has made a cumulative investment of approximately Rs 4,500 crores.
FIDELITY ASIAN VALUES PLCFinal Results for the year ended 31 July 2023 ...
LUXEMBOURG, October 11, 2023--Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022.
LUXEMBOURG--(BUSINESS WIRE)--Oct 11, 2023--
Indian pharmaceutical companies have immense potential to increase their share in the $1.4 trillion global pharma industry The global pharmaceutical space has witnessed massive evolution in the last three years, following the pressure mounted by the COVID-19 pandemic. Within a short period, India